InvestorsHub Logo

ziploc_1

06/01/23 8:48 AM

#409936 RE: AGORDON #409934

A...QUOTE.."On February 23, 2022, The Hong Kong Department of Health concluded their evaluation and approved the use of VASCEPA under the REDUCE-IT indication."